Phillip Proger

U.S. Supreme Court Reverses "State Action" Decision, Confirming Narrow Scope Of Immunity

Antitrust Alert: New FTC Pharma Patent Litigation Report Finds Increase In "Reverse Payment" Settlements Based On Expanded Definition Of "Payments"

FTC Releases Report On Authorized Generic Drugs

Federal Antitrust Enforcers Taking More Regulatory, but More Flexible, Approach to Merger Remedies

U.S. And EU Antitrust Authorities Impose Extraordinary Fines In Two New Enforcement

U.S. Court Of Appeals Upholds Validity Of "Reverse Payment" Patent Settlements